Abstract
Following an editorial in the BMJ on optimising prenatal diagnosis of
Down’s syndrome (1), a recent report by Dhallan et al (2) on the potential
for risk-free prenatal diagnosis of Down’s syndrome (DS) by the use of
maternal blood samples alone has attracted much media attention. There
have also recently been a number of other reports (3,4) indicating that
this might soon become a viable alternative to current prenatal diagnosis,
where unfortunately amniocentesis and chorionic villus sampling (CVS) are
associated with a fetal loss rate of around 0.5-1%.
Original language | English |
---|---|
Journal | BMJ |
Volume | 332 |
Issue number | 433 |
DOIs | |
Publication status | Published - 7 Feb 2007 |